Positive effect of tamoxifen as part of adjuvant chemo-endocrine therapy for breast cancer. Hokkaido Adjuvant Chemo-Endocrine Therapy for Breast Cancer Study Group.

A prospective randomised multicentre clinical study was undertaken for 2 years and 3 months from November 1982, with the aim of examining the significance of using a combination of ftorafur (FT) and tamoxifen (TAM) for post-operative adjuvant therapy of breast cancer. Patients had either stage II or...

Descripción completa

Detalles Bibliográficos
Autores principales: Uchino, J., Samejima, N., Tanabe, T., Hayasaka, H., Mito, M., Hata, Y., Asaishi, K.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1994
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1968816/
https://www.ncbi.nlm.nih.gov/pubmed/8142265

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1968816/
https://www.ncbi.nlm.nih.gov/pubmed/8142265

Ejemplares similares